Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · IEX Real-Time Price · USD
44.46
-0.23 (-0.50%)
Jul 22, 2024, 10:14 AM EDT - Market open
Janux Therapeutics Employees
Janux Therapeutics had 64 employees as of December 31, 2023. The number of employees increased by 4 or 6.67% compared to the previous year.
Employees
64
Change (1Y)
4
Growth (1Y)
6.67%
Revenue / Employee
$113,859
Profits / Employee
-$868,656
Market Cap
2.39B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 64 | 4 | 6.67% |
| Dec 31, 2022 | 60 | 27 | 81.82% |
| Dec 31, 2021 | 33 | 21 | 175.00% |
| Dec 31, 2020 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Addus HomeCare | 34,846 |
| Ardent Health Partners | 23,000 |
| Amneal Pharmaceuticals | 7,700 |
| Patterson Companies | 7,600 |
| QuidelOrtho | 7,100 |
| CONMED | 4,000 |
| STAAR Surgical Company | 1,115 |
| Privia Health Group | 1,102 |
JANX News
- 2 months ago - Janux Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights - Business Wire
- 2 months ago - Janux Therapeutics (JANX) stock has gone parabolic: what next? - Invezz
- 3 months ago - VKTX, JANX and these biotech stocks are surging in 2024 - Invezz
- 4 months ago - Cancer-Focused Janux Therapeutics Platform Has 'Tremendous Opportunity': Analyst - Janux Therapeutics (NASDAQ:JANX) - Benzinga
- 4 months ago - Janux Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights - Business Wire
- 5 months ago - Janux Therapeutics Announces Pricing of $296.5 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants - Business Wire
- 5 months ago - Janux Therapeutics Announces Proposed Public Offering of Common Stock - Business Wire
- 5 months ago - Janux Therapeutics surges as trial data for prostate cancer therapy shows promise - Reuters